Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

Mixed Connective Tissue Disease can develop from overlapping symptoms of several autoimmune diseases, making diagnosis complex.

Enhancing glycolysis in mesenchymal stromal/stem cells boosts their immune functions and therapy potential.

MC-DNA vector-based gene therapy can temporarily treat CBS deficiency in mice.

New technologies show promise in healing wounds, treating cancer, autoimmune diseases, and genetic disorders.

RCS-01 therapy is safe and may improve skin structure by affecting gene expression.

Efficient delivery systems are needed for the clinical use of CRISPR-Cas9 gene editing.

Sacituzumab govitecan improves quality of life and symptoms in breast cancer patients, except for causing more diarrhea.

Probiotics help improve skin wound healing in diabetic rats.

Ancient immune and signaling pathways still regulate blood cell development.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

Flexible bioelectronics show promise in non-invasive cancer detection and treatment but need improvements in stability and effectiveness.

The silk fibroin-based hydrogel shows promise for treating melanoma and healing infected wounds by killing tumor cells and bacteria, and supporting skin recovery.

Cetirizine-loaded gel may effectively promote hair growth in alopecia.

Minocycline reduces acne rash, pyridoxine lowers hand-foot syndrome risk, and scalp cooling lessens hair loss from cancer treatments.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

The document concludes that diagnosing and treating Interstitial Pneumonia with Autoimmune Features (IPAF) is challenging, needs a multidisciplinary approach, and further research for better diagnostic criteria and treatments. It also emphasizes regular checks for Connective Tissue Disease symptoms in all patients with Interstitial Lung Disease.

Cis-UCA can form new compounds without enzymes, and sulphide donors reduce its UVB-induced toxicity in skin cells.

Metabolism plays a key role in determining stem cell fate.

Improving mesenchymal stromal cell therapies requires overcoming cell death and optimizing delivery methods.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

FOXN1 mutations can cause varying immune and physical issues, with severity influenced by gene activity and possibly other factors.

Most pediatric cancer patients at Muhimbili National Hospital in Tanzania experienced side effects from chemotherapy, with nausea, hair loss, and low white blood cell count being the most common.

Low CD4 counts in HIV patients are linked to more skin disorders.

New drug delivery methods can make natural compounds more effective and stable.

About half the patients treated with capecitabine and docetaxel developed severe hand-foot syndrome.

Six existing drugs may help block virus entry in COVID-19.

Some diseases can improve the outcomes of other diseases, leading to new treatment possibilities.